Fundraising

McWin Partners has launched McWin Food Tech Fund, a €250 million vehicle that will target the whole food value chain, including “ingredients and alternative proteins," said partner Martín Dávalos.

Amplify Partners, an early stage investor based in Menlo Park, raised $400 million for its fifth early-stage fund and $300 million for a fund to support existing portfolio companies.

Healthcare investor Third Rock Ventures has closed on just over $1.1 billion from 65 investors for its sixth fund, Third Rock Ventures VI, according to a regulatory filing.

Life sciences investor Catalio Capital Management has been on a fundraising tear since it spun out of private equity firm Camden Partners Holdings slightly more than two years ago. If dealmaking continues to founder in a sputtering economy, Catalio will be well positioned to take advantage of declining valuations.

Seae Ventures, founded by the former leaders of a Blue Cross corporate venture fund, announced it has raised an inaugural fund of $107m to support diverse-led companies.

UP.Partners has closed its $230 million for its inaugural transportation tech-focused venture fund.

The fund will back startups "whose technologies have the potential to improve quality of life and conserve natural resources."

The Column Group is close to reaching its fundraising target of $600m apiece for its early-stage life science Fund V and later-stage Opportunity Fund III.

The firm expects to make 40 to 50 investments, ranging from $250,000 to $500,000, from its first fund.

The fund will invest in early-stage therapeutics and healthcare tech companies in the U.S. and the EU.